Scroll to top

News

CLINUVEL
Posted by CLINUVEL
October 29, 2020

CLINUVEL Strategic Update – Extended

CLINUVEL PHARMACEUTICALS LTD today released a strategic update on its business. An...

Read More
CLINUVEL
Posted by CLINUVEL
October 29, 2020

APPENDIX 4C AND ACTIVITY REPORT

KEY HIGHLIGHTS: SEPTEMBER QUARTER 2020 • Cash receipts of $12,015,000 • Operating...

Read More
CLINUVEL
Posted by CLINUVEL
October 29, 2020

CLINUVEL Strategic Update – Executive Summary

CLINUVEL PHARMACEUTICALS LTD today released a strategic update on its business. An...

Read More
CLINUVEL
Posted by CLINUVEL
October 28, 2020

Afamelanotide for Acute Stroke Patients

EXECUTIVE SUMMARY • World’s first pilot study (CUV801) to evaluate afamelanotide in...

Read More
CLINUVEL
Posted by CLINUVEL
October 27, 2020

Media Release – CLINUVEL to Trial Innovative Drug in Stroke

The drug afamelanotide will be used for the first time in patients...

Read More
CLINUVEL
Posted by CLINUVEL
October 27, 2020

Media Release – TGA approves Australian drug to protect patients from light and sun

New Australian-developed drug approved by TGA for metabolic disorder erythropoietic protoporphyria (EPP)...

Read More
CLINUVEL
Posted by CLINUVEL
October 27, 2020

Australian TGA approves SCENESSE®

Executive summary SCENESSE® approved by Australian TGA under Priority Review First approved...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2020

Update: SCENESSE® in DNA Repair

CLINUVEL PHARMACEUTICALS LTD provided today a clinical update on the use of...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2020
CLINUVEL
Posted by CLINUVEL
October 14, 2020

Further Research Coverage Initiated on CLINUVEL

CLINUVEL PHARMACEUTICALS LTD today informed its shareholders and interested investors that Jefferies...

Read More
CLINUVEL
Posted by CLINUVEL
October 9, 2020
CLINUVEL
Posted by CLINUVEL
October 9, 2020

Appendix 4G and Corporate Governance Statement

Download Appendix 4G and Corporate Governance Statement

Read More
CLINUVEL
Posted by CLINUVEL
October 9, 2020

CLINUVEL Annual General Meeting 2020

CLINUVEL PHARMACEUTICALS LTD’s 2020 Annual General Meeting (AGM) will be held on...

Read More
CLINUVEL
Posted by CLINUVEL
October 9, 2020

CLINUVEL Annual Report 2020

Download Annual Report

Read More
CLINUVEL
Posted by CLINUVEL
October 7, 2020

SCIENTIFIC COMMUNIQUÉ VI

Ultraviolet Radiation Damage and Oxidative Stress in Skin Cancer. October 2020 Introduction...

Read More
CLINUVEL
Posted by CLINUVEL
October 6, 2020

CLINUVEL News & Facts site live

Earlier this week CLINUVEL launched a new microsite, CLINUVEL News & Facts. The CLINUVEL...

Read More
We use cookies to give you the best experience.